Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma | |
Ambrogio, Chiara ; Gomez-Lopez, Gonzalo ; Falcone, Mattia ; Vidal, August ; Nadal, Ernest ; Crosetto, Nicola ; Blasco, Rafael B. ; Fernandez-Marcos, Pablo J. ; Sanchez-Cespedes, Montserrat ; Ren, Xiaomei ; Wang, Zhen ; Ding, Ke ; Hidalgo, Manuel ; Serrano, Manuel ; Villanueva, Alberto ; Santamaria, David ; Barbacid, Mariano | |
刊名 | NATURE MEDICINE |
2016 | |
卷号 | 22期号:3页码:270-277 |
ISSN号 | 1078-8956 |
学科主题 | Biochemistry & Molecular Biology ; Cell Biology ; Research & Experimental Medicine |
语种 | 英语 |
公开日期 | 2016-12-16 |
内容类型 | 期刊论文 |
源URL | [http://ir.gibh.ac.cn/handle/344009/884] |
专题 | 广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文 |
推荐引用方式 GB/T 7714 | Ambrogio, Chiara,Gomez-Lopez, Gonzalo,Falcone, Mattia,et al. Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma[J]. NATURE MEDICINE,2016,22(3):270-277. |
APA | Ambrogio, Chiara.,Gomez-Lopez, Gonzalo.,Falcone, Mattia.,Vidal, August.,Nadal, Ernest.,...&Barbacid, Mariano.(2016).Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.NATURE MEDICINE,22(3),270-277. |
MLA | Ambrogio, Chiara,et al."Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma".NATURE MEDICINE 22.3(2016):270-277. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论